Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2022 Dec 30;17(12):e0279725. doi: 10.1371/journal.pone.0279725

Patient-Centered Communication (PCC) scale: Psychometric analysis and validation of a health survey measure

Richard P Moser 1,*,#, Neha Trivedi 2,#, Ashley Murray 1,#, Roxanne E Jensen 3,#, Gordon Willis 1,#, Kelly D Blake 1,#
Editor: Nabi Nazari4
PMCID: PMC9803193  PMID: 36584146

Abstract

Introduction

Patient-centered communication (PCC) is one important component of patient-centered care and seen as a goal for most clinical encounters. Previous research has shown that higher PCC is related to an increase in healthy behaviors and less morbidity, among other outcomes. Given its importance, the National Cancer Institute (NCI) commissioned a monograph in 2007 to synthesize the existing literature on PCC and determine measurement objectives and strategies for measuring this construct, with a particular focus on cancer survivors. Based on this effort, a seven-item PCC scale was included on the Health Information National Trends Survey (HINTS), a probability-based survey of the US adult population. This study used HINTS data collected in 2018 to evaluate the psychometric properties of the PCC scale for the general US adult population including measures of reliability and validity.

Results

Through an exploratory factor analysis, the seven-item PCC scale was shown to be unidimensional with good internal consistency (Cronbach’s alpha = .92). A confirmatory factor analysis verified the factor structure. Other construct validity metrics included known groups and discriminant validity. Known group comparisons were conducted for several sociodemographic factors and health self-efficacy confirming a priori assumptions. Discriminant validity tests with measures of social support and anxiety/depression showed relatively weak associations.

Conclusions

The psychometric properties of this scale demonstrate its scientific utility for both surveillance research and other smaller-scale studies. Given its association with many health outcomes, it can also be used to better understand the dynamics in a clinical encounter.

Introduction

Patient-centered care, defined as care that is respectful of and responsive to a patient’s preferences and values [1] is seen as one important goal for clinical encounters, and increasing patient-centered communication (PCC) is a way of achieving this goal. Most experts agree that PCC should focus on understanding the patient’s perspective and values and supporting the patient in making health decisions that are concordant with these goals [24] and thus is seen as an important component of social support [2, 4]. PCC also supports shared decision making [5], which is another important element of healthcare quality.

Research has shown that better PCC is associated with several health outcomes including higher quality of life in cancer survivors [6], higher cancer screening behaviors [7], and other psychological outcomes such as increased health-related self-efficacy, that is, the confidence in one’s ability to take care of one’s health [8, 9]; lower anxiety, less negative affect, and higher physician trust [10]. Higher PCC in the clinical encounter is also associated with higher self-efficacy for those with multiple chronic health conditions [8] and is critical for patient self-management and a sense of agency in treating one’s disease(s). Higher PCC is associated with patient demographics including gender (females), age (older), race-ethnicity (White), and increased healthcare use [9, 11]. PCC is clearly an important factor to assess given its associations with several significant health outcomes and is especially important to understand when treating those with chronic and debilitating diseases to increase self-efficacy given the myriad clinical encounters they will assumedly experience and the need to keep track of their treatment and treatment decisions over the course of the disease.

In 2007 the National Cancer Institute (NCI) commissioned a monograph titled “Patient-Centered Communication in Cancer Care: Promoting Healing and Reducing Suffering” to synthesize the existing literature on PCC, determine measurement objectives and strategies for measuring PCC, and identify gaps in research for cancer survivors in particular [4]. The monograph outlined six critical elements of PCC that are applicable to any clinical encounter: 1) Responding to emotions; 2) Exchanging information; 3) Making decisions; 4) Fostering healing relationships; 5) Enabling patient self-management; 6) Managing uncertainty. It focused on PCC among cancer patients and their significant communication needs given the complex nature of cancer care which oftentimes involves coordination among providers. Related to their cancer treatment, many people also experience negative psychological and physical reactions to cancer treatment [12, 13] and have fatalistic perceptions of a cancer diagnosis [14] and so have other physical, psychological, and emotional considerations that need to be addressed during clinical encounters. However, these issues also apply to other acute and chronic diseases beyond cancer, making PCC an important facet of treatment for all patient-provider encounters.

Given the importance of PCC for many health-related outcomes, the National Cancer Institute’s Health Information National Trends Survey (HINTS; https://hints.cancer.gov/) added PCC items to the survey starting in 2008 (HINTS 3), reflecting the core elements of PCC as defined by the NCI monograph [4]. These items have been included on every iteration since HINTS 3 (2008), including the most recent iteration in 2020, and these items have been used in numerous studies as predictors, modifiers, and outcomes. This study will assess the psychometric properties of the PCC scale used in HINTS, and though the psychometric properties of this measure along with other PCC scales have been assessed previously for cancer survivors [15], this is the first study of which we are aware that assesses this PCC scale in a nationally-representative U.S. general adult population. We hypothesized that the psychometric analysis would verify that the PCC scale is unidimensional, with strong internal consistency (reliability), construct validity, with significant positive associations with self-reported health self-efficacy, female gender, education, and age. To demonstrate discriminant validity, given previous research regarding social support being a component of PCC and PCC being related to anxiety, we hypothesized that PCC scores would be positively, but weakly associated with social support and negatively, but weakly associated with anxiety and depression.

Materials and methods

Data source

The test of the psychometric properties of the PCC scale used data from HINTS 5 Cycle 2 gathered from January through May of 2018 with an overall response rate of 32.9% (n = 3,504). Though there have been subsequent iterations of HINTS that could be used, this dataset was one of the most recent when this paper was conceptualized and all HINTS samples are representative of the same population, that is, non-institutionalized US adults eighteen and older. We were also able to take advantage of other existing items on this iteration that could be used to test construct and discriminant validity. HINTS is a probability-based complex sample survey that assesses the American public’s use of health and cancer-related information and related knowledge, perceptions, and behaviors in the context of a changing communication environment. Information about the stratified sampling design, creation of the weights, and response rate calculation details are available publicly from the following website: http://hints.cancer.gov/.

HINTS 5 Cycle 2 used an address-based frame. Households were randomly chosen and sent a mail survey wherein the adult (18 or older) with the “Next Birthday” was requested to fill out the survey. A waiver of documentation of informed consent was approved as the research presents no more than minimal risk of harm to subjects and involves no procedures for which written consent is normally required outside of the research context. Further details on the overall design and study operations are published elsewhere. Given that this study used secondary data that were de-identified, it was considered “not human subjects research” according to the NIH and thus did not require an IRB determination.

Scale items

Patient-Centered Communication (PCC) scale

The PCC scale consists of seven items, using concepts from Epstein and Street (4), that probe about the respondents’ experience with their provider. The scale states “…during the past 12 months…”, “…how often did your doctors, nurses or other health care professionals… do the following…”: 1) “Give you the chance to ask all the health-related questions you had”; 2) “Give the attention you needed to your feelings and emotions”; 3) “Involve you in decisions about your health care as much as you wanted”; 4) “Make sure you understood the things you needed to do to take care of your health”; 5) “Explain things in a way you could understand”; 6) “Spend enough time with you”; 7) “Help you deal with feelings of uncertainty about your health or health care.” The PCC scale uses a Likert-like four-point scale: Always (1), Usually (2), Sometimes (3) and Never (4). Scale scores are created by reverse-scoring all items, summing all scores and taking the average and doing a linear transformation to change the range from 0 to 100 with higher scores meaning better communication with one’s provider.

The HINTS survey included skip logic, wherein only respondents who saw their provider in the past 12 months completed the PCC scale (n = 2940). A minimum of four valid PCC item responses were needed to generate a PCC scale score.

Sociodemographic variables

On HINTS the following sociodemographic self-report data were collected and coded into the following categories: Gender (Female/Male); Age (18–35, 36–64; 65+); Race/ethnicity: (Non-Hispanic White vs. Non-White [includes Latino, Non-Hispanic Black/Asian/Other]). These were used to test for construct validity of the PCC scale.

Health self-efficacy

Health self-efficacy, an item tested and developed for HINTS, was measured by asking respondents, “Overall, how confident are you about your ability to take good care of your health?” and was dichotomized to Not at all Confident\A Little Confident\Somewhat Confident vs. Very\Completely Confident. This item was used to test for construct validity.

PROMIS instrumental support measure (4a)

HINTS 5 Cycle 2 included the 4-item PROMIS Instrumental Support Measure and was used to assess the discriminant validity of the PCC scale given its association. This Measure assesses social support and specific functional aspects of these relationships, with an emphasis on health-related support. Items include: 1) “Do you have someone to prepare your meals if you are unable to do it yourself?”; 2) Do you have someone to take you to the doctor if you need it?; 3) Do you have someone to help with your daily chores if you are sick?; 4) Do you have someone to run errands if you need it?, with response options of Never, Rarely, Sometimes, Often, Always (1–5). Raw scores were converted to a T score metric, calibrated to reflect a general population mean of 50 and 10 points reflecting a standard deviation in the general population. Previous research showed the Cronbach’s alpha for this scale is α = 0.96 [16]. See for more information: http://www.healthmeasures.net/images/PROMIS/manuals/PROMIS_Instrumental_Support_Scoring_Manual.pdf).

Patient-Health Questionnaire 4 (PHQ4)

The PHQ4 is found on almost all HINTS iterations and was used to test for discriminant validity of the PCC scale. The PHQ4 was developed by Kroenke et al. [17] as a screening tool to measure anxiety and depression and is included in HINTS. It consists of four items that ask respondents, “Over the past 2 weeks, how often have you been bothered by any of the following problems?” in regards to 1)”Little interest or pleasure in doing things”; 2) “Feeling down, depressed, or hopeless”; 3) “Feeling nervous, anxious, or on edge; and 4) “Not being able to stop or control worrying”. Response options include “Nearly every day” (1), “More than half the days” (2), “Several days” (3), and “Not at all” (4). Scale scores are created by first rescoring the items from 0–3, reverse scoring the items and then summing them, thus total scores range from 0–12 with higher scores indicating more depression and anxiety. The PHQ4 has been shown to have good internal reliability, construct validity, and factorial validity [17].

Statistical analysis

We first computed weighted descriptive statistics of the respondents. Next, unweighted descriptive statistics for the PCC scale items and scale were calculated, including measures of central tendency. Aspects of data quality were measured through the percent missing by item. The internal consistency (a measure of reliability) of the PCC scale was determined by examining item-total correlations, Cronbach’s alpha, and an exploratory factor analysis. Next, construct validity was measured through a confirmatory factor analysis (CFA) of a one-factor structure—with the variance fixed to 1 to free the factor loadings—and verifying known-group differences between variables previously assessed in the literature [15] and included on HINTS 5 Cycle 2 including health self-efficacy, race/ethnicity, gender and age. For the CFA, fit was determined using the following fit indices: Root Mean Square Error of Approximation (RMSEA, cut off < .08), Comparative Fit Index (CFI, cut off >.90), Tucker Lewis Index (TLI, cut off >.95), and Standardized Root Mean Square Residual (SRMR, cut off < .08). We did not report the chi square statistic fit as research has found that this test is sensitive to large sample sizes. The known-group differences analysis was done with weighted t-tests and means are presented to illustrate any differences. Lastly, discriminant validity was calculated by examining the Pearson correlation between the PCC scale and the PROMIS social support scale and the PHQ4. Discriminant validity is shown by having associations, albeit weakly, between PCC and the other scales [18] Note that p-values are not typically reported for these analyses and interpretation of a significant p value (i.e., p < .05) could be misleading given the relatively large sample size used here.

Results

Descriptive statistics

See Table 1 for a description of the HINTS 5 Cycle 2 sample used in this analysis. The overall PCC scale mean was 79.75 (range 0–100) with a median of 85.7 and skewness = -.95. Note that 33% of the sample had a PCC score of 100, the highest score possible, indicating a ceiling effect.

Table 1. Unweighted cell sizes and weighted percentages of the HINTS 5 Cycle 2 sample (n = 2940) of those who visited their provider in the last 12 months and had a valid PCC score.

Characteristic Sample Size Percentage (95% CI)
Gender
Male 1121 45.2 (43.8, 46.6)
Female 1777 54.7 (53.4, 56.1)
Age
18–35 344 22.8 (20.3, 25.3)
36–50 555 28.4 (25.8, 30.9)
51–64 880 27.2 (25.0, 29.3)
65+ 1095 21.6 (20.7, 22.5)
Education
Less than high school 210 7.3 (5.5, 9.0)
High school graduate 512 21.2 (19.1, 23.3)
Some college 871 40.2 (37.9, 42.4)
College grad or more 1309 31.3 (30.1, 32.6)
Race/Ethnicity
Non-Hispanic White 1739 67.6 (66.1, 69.2)
Non-Hispanic Black/AA 367 10.3 (9.3, 11.3)
Non-Hispanic Asian 105 5.1 (4.1, 6.2)
Hispanic 343 13.3 (12.2, 14.4)
Non-Hispanic Other/Multiple Races 107 3.6 (2.9, 4.3)

Reliability

Internal consistency was assessed by calculating Cronbach’s Alpha for PCC scores and was α = 0.92. Descriptive statistics (mean, % missing) for each item and the item-total score correlations and Cronbach’s alpha if item deleted can be seen in Table 2. Results of the exploratory factor analysis showed one factor through the scree plot which was further supported by an eigenvalue greater than 1 (factor 1 = 12.34; no other factors had an eigenvalue greater than 1). Factor loadings (for one factor) ranged from .78 to .83.

Table 2. PCC scale items, means, % missing, standardized variables item/total correlations and alpha if item deleted.

PCC Scale Item* Mean (range = 1–4) % Missing Correlation with Item Total Cronbach’s Alpha if Deleted
Questions 3.54 1.62 0.74 0.920
Attention 3.25 2.03 0.78 0.917
Decisions 3.41 2.03 0.79 0.916
Understood 3.54 1.93 0.80 0.915
Explain 3.59 2.03 0.76 0.919
Time 3.26 2.33 0.78 0.916
Feelings 3.17 2.57 0.76 0.919

* Full text of item

Question: “Give you the chance to ask all the health-related questions you had”

Attention: “Give the attention you needed to your feelings and emotions”

Decisions: “Involve you in decisions about your health care as much as you wanted”

Understood: “Make sure you understood the things you needed to do to take care of your health”

Explain: “Explain things in a way you could understand”

Time: “Spend enough time with you”

Feelings: “Help you deal with feelings of uncertainty about your health or health care.”

Validity

Construct validity

Confirmatory factor analysis. Results of the EFA supported the unidimensionality of the PCC scale, so a one-factor confirmatory factor analysis was conducted to test the fit of this model. Factor loadings and model fit statistics from this analysis can be found in Table 3 (with cut-offs indicating good fit). Overall, the CFA indicated good fit for a 7-item unidimensional scale.

Table 3. Standardized factor loadings and fit statistics for confirmatory factor analysis of the PCC scale.
Item Factor Loading
Give you the chance to ask all the health-related questions you had .858
Give the attention you needed to your feelings and emotions .877
Involve you in decisions about your health care as much as you wanted .884
Make sure you understood the things you needed to do to take care of your health .919
Explain things in a way you could understand .900
Spend enough time with you .877
Help you deal with feelings of uncertainty about your health or health care .867

Fit indices (cut-off for good fit)

RMSEA (Root Mean Square Error Of Approximation): 0.118 (< .08)

CFI (Comparative Fit Index): 0.991 (>.90)

TLI (Tucker Lewis Index): 0.986 (>.95)

SRMR (Standardized Root Mean Square Residual): 0.022 (< .08)

Known group differences

Previous research with data other than HINTS has shown group differences in PCC scores regarding health self-efficacy, gender, race/ethnicity, and age with PCC being positively associated with higher values of self-efficacy, being female, White and being older. This analysis assessed for these hypothesized group differences using HINTS. T-tests showed that the following variables exhibited significant between group differences in the hypothesized direction: health self-efficacy (high confidence > low confidence) and race/ethnicity (White > Non-White); groups defined by age and gender, though trending in the expected direction, were not significantly different. Table 4 presents the weighted means, standard errors, mean differences and p values for each group comparison.

Table 4. Known-group comparisons, weighted means, standard errors, mean group differences and probabilities for PCC scale scores (Significant differences, alpha = .05, bolded).

Known-Group Comparison Hypothesized Higher PCC Scores Group 1 Mean (SE) Group 2 Mean (SE) Mean Group Difference (SE) P Value
Health Self-Efficacy (High vs. Low Confidence) High Confidence 82.19 (.63) 75.80 (1.32) 6.40 (1.32) < .0001
Age 18–35 vs. 65+ 65+ 78.41 (1.69) 81.76 (.98) -3.35 (1.80) .069
Female vs. Male Female 80.90 (.83) 79.52 (.97) 1.37 (1.29) .293
White vs. Non-White White 81.48 (.78) 77.50 (1.35) 3.98 (1.64) .019

Discriminant validity

As mentioned previously, discriminant validity is shown by having associations, albeit weakly, between PCC and other theoretically related items [18]. For this analysis, we were able to utilize two existing scales found on HINTS 5 Cycle 2, Instrumental Support (PROMIS) and the PHQ4. Results of the Pearson correlation between PCC and Instrumental Support showed the two scales were weakly correlated (Pearson correlation = .19). The Pearson correlation between PCC and the PHQ4 showed a negative association that was also relatively weak (-.14). The directions of the associations were in the hypothesized direction.

Discussion

Based on a conceptual model and utilizing a nationally representative sample of US adults, the psychometric properties of the Patient-Centered Communication scale were assessed and found to show good reliability and validity. Several of the expected group differences were found, with education and age as notable exceptions. Regarding measures of data quality, across items there was a small amount of missing data seemingly showing that people understood and were comfortable answering each question though there was a tendency for respondents to answer “Always” for each PCC item. This outcome may signify satisficing, that is, putting in minimal effort to answer the questions, but a better explanation may be that the PCC scale is showing some ceiling effects and difficulty with discerning differences at the higher end of the scale, which is a limitation of this scale. Ceiling effects are oftentimes seen in patient-provider communication scales [19] and other measures of healthcare satisfaction like the Consumer Assessment of Healthcare Providers and Systems (CAHPS) [20]. An alternative interpretation is that most adults are at least somewhat satisfied with their clinical encounters, and it would be useful to replicate these results with other data and especially with data from providers regarding their usual practice. We are not aware of other data sources with information on providers regarding this practice. Another mitigating factor that lessens concerns is that the PCC showed a minimal floor effect (i.e., about .2% of respondents scored the lowest value on the PCC scale), so this measure is particularly sensitive to communication deficits.

Given the rigorous study of patient-provider communication and strong conceptual model on which the PCC scale was designed, it was not surprising to confirm the association of the individual components and the overall unidimensional nature of the measure, which is consistent with other similar analyses [15]. Fit indices were good for almost all metrics. Expected group differences in self-efficacy and race/ethnicity make conceptual sense and replicated previous research. A lack of group differences by gender and age was unexpected, although the trend for females and older respondents to have higher PCC was observed (though not statistically significant). Perhaps these variables interact with other variables in explaining PCC differences and future research can test this out. Discriminant validity indices, showing weak associations suggest that though there is overlap in variance explained between PCC and the other scales, the PCC scale also appears to explain unique variance which supports its use as an independent variable.

This study had several limitations. Responses were self-reported and may be subject to a variety of cognitive biases. The PCC scale also provides an overall perception of clinical encounters during the past 12 months as opposed to focusing on any specific provider and so may be interpreted as a gestalt view of a typical encounter. Given the cross-sectional nature of the survey, we couldn’t assess other aspects of reliability such as test-retest. Lastly, there were not enough responses for Spanish speakers so it’s not clear if the results would generalize to other languages.

Clinical implications

Given the increased focus on the “activated” patient and the importance of shared decision making between patient and provider, the PCC scale has practical applicability for both public health and clinical researchers and patient advocates and providers. For researchers, understanding prevalence of PCC at a population or sub-population level (e.g., state or county; specific racial/ethnic groups) and assessing for any correlates or causes (e.g., social determinants of health) will provide ideas for clinicians or patient advocates to intervene in certain geographic areas or with specific groups. A PCC assessment could be embedded in health systems and assessed regularly similar to how smoking status is now asked. Once identified, educating patients about the importance of asking questions and making sure emotional needs are addressed can be stressed. Likewise, it is critical that providers receive education in good communication skills as research has shown positive patient outcomes associated with better provider communication [21] and so professional organizations have advocated for this type of training in medical education.

Conclusions

In summary, the PCC scale showed strong internal consistency and good construct validity and discriminant validity. The scale is unidimensional though it did show some ceiling effects similar to other communication measures. It did not show floor effects and seems particularly useful for assessing deficits in patient-provider communication. PCC continues to be included in HINTS iterations and future research could test for trends in this outcome over time and examine any differential change by important sociodemographic variables such as gender, race/ethnicity, and age. Other validation could be done with cut-points or percentiles to further elucidate the utility of the scale. The PCC scale could be included in other population-level health surveys like HINTS to compare across surveys or to test with targeted populations. Lastly, this is also a relatively short scale that could be incorporated into the clinical setting to assess this important construct.

Acknowledgments

Disclaimers: The article was prepared as part of the authors’ official duties as employees or fellows of the US Federal Government. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the National Cancer Institute.

Data Availability

All data used for this manuscript are available to the public and can be accessed through this site after accepting a data use agreement: https://hints.cancer.gov/data/download-data.aspx. This study specifically used the HINTS 5 Cycle 2 data (2018).

Funding Statement

There were no external sources of funding for hits project.

References

  • 1.Institute of Medicine. Crossing the Quality Chasm: A New Health System for the 21st Century. Washington (DC)2001.
  • 2.McCormack LA, Treiman K, Rupert D, Williams-Piehota P, Nadler E, Arora NK, et al. Measuring patient-centered communication in cancer care: a literature review and the development of a systematic approach. Soc Sci Med. 2011;72(7):1085–95. doi: 10.1016/j.socscimed.2011.01.020 [DOI] [PubMed] [Google Scholar]
  • 3.Naughton CA. Patient-Centered Communication. Pharmacy (Basel). 2018;6(1). doi: 10.3390/pharmacy6010018 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Epstein RMS, R. L. Jr. Patient-centered communication in cancer care: Promoting healing and reducing suffering. National Cancer Institute, 2007. [Google Scholar]
  • 5.Smith MA. The Role of Shared Decision Making in Patient-Centered Care and Orthopaedics. Orthop Nurs. 2016;35(3):144–9. doi: 10.1097/NOR.0000000000000243 [DOI] [PubMed] [Google Scholar]
  • 6.Street RL, Voigt B. Patient participation in deciding breast cancer treatment and subsequent quality of life. Med Decis Making. 1997;17(3):298–306. doi: 10.1177/0272989X9701700306 [DOI] [PubMed] [Google Scholar]
  • 7.Totzkay D, Silk KJ, Sheff SE. The Effect of Electronic Health Record Use and Patient-Centered Communication on Cancer Screening Behavior: An Analysis of the Health Information National Trends Survey. Journal of Health Communication. 2017;22(7):554–61. doi: 10.1080/10810730.2017.1338801 [DOI] [PubMed] [Google Scholar]
  • 8.Finney Rutten LJ, Hesse BW, St Sauver JL, Wilson P, Chawla N, Hartigan DB, et al. Health Self-Efficacy Among Populations with Multiple Chronic Conditions: the Value of Patient-Centered Communication. Adv Ther. 2016;33(8):1440–51. doi: 10.1007/s12325-016-0369-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Trivedi NM, R; Breslau E; Chou W S Predictors of Patient-Centered Communication among U.S. Adults: Analysis of the 2017–2018 Health Information National Trends Survey (HINTS). Journal of Health Communication. 2021. doi: 10.1080/10810730.2021.1878400 [DOI] [PubMed] [Google Scholar]
  • 10.Zwingmann J, Baile WF, Schmier JW, Bernhard J, Keller M. Effects of patient-centered communication on anxiety, negative affect, and trust in the physician in delivering a cancer diagnosis: A randomized, experimental study. Cancer. 2017;123(16):3167–75. doi: 10.1002/cncr.30694 [DOI] [PubMed] [Google Scholar]
  • 11.Singh S, Evans N, Williams M, Sezginis N, Baryeh NAK. Influences of Socio-Demographic Factors and Health Utilization Factors on Patient-Centered Provider Communication. Health Commun. 2018;33(7):917–23. doi: 10.1080/10410236.2017.1322481 [DOI] [PubMed] [Google Scholar]
  • 12.Tsaras K, Papathanasiou IV, Mitsi D, Veneti A, Kelesi M, Zyga S, et al. Assessment of Depression and Anxiety in Breast Cancer Patients: Prevalence and Associated Factors. Asian Pac J Cancer Prev. 2018;19(6):1661–9. doi: 10.22034/APJCP.2018.19.6.1661 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Chung NC, Walker AK, Dhillon HM, Vardy JL. Mechanisms and Treatment for Cancer- and Chemotherapy-Related Cognitive Impairment in Survivors of Non-CNS Malignancies. Oncology (Williston Park). 2018;32(12):591–8. [PubMed] [Google Scholar]
  • 14.Moser RP, Arndt J, Han PK, Waters EA, Amsellem M, Hesse BW. Perceptions of cancer as a death sentence: prevalence and consequences. J Health Psychol. 2014;19(12):1518–24. doi: 10.1177/1359105313494924 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Reeve BB, Thissen DM, Bann CM, Mack N, Treiman K, Sanoff HK, et al. Psychometric evaluation and design of patient-centered communication measures for cancer care settings. Patient Educ Couns. 2017;100(7):1322–8. doi: 10.1016/j.pec.2017.02.011 [DOI] [PubMed] [Google Scholar]
  • 16.Hahn EA, Devellis RF, Bode RK, Garcia SF, Castel LD, Eisen SV, et al. Measuring social health in the patient-reported outcomes measurement information system (PROMIS): item bank development and testing. Qual Life Res. 2010;19(7):1035–44. doi: 10.1007/s11136-010-9654-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Kroenke K, Spitzer RL, Williams JB, Lowe B. An ultra-brief screening scale for anxiety and depression: the PHQ-4. Psychosomatics. 2009;50(6):613–21. doi: 10.1176/appi.psy.50.6.613 [DOI] [PubMed] [Google Scholar]
  • 18.Jensen RE, Potosky AL, Reeve BB, Hahn E, Cella D, Fries J, et al. Validation of the PROMIS physical function measures in a diverse US population-based cohort of cancer patients. Qual Life Res. 2015;24(10):2333–44. doi: 10.1007/s11136-015-0992-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Gonzalez AIK, J T P; Rijk L; Ring D; Brown L E. Is there a correlation between the patient-doctor relationship questionnaire and other patient-reported experience measures? Patient Experience Journal. 2020;7(1). [Google Scholar]
  • 20.Evensen CT, Yost KJ, Keller S, Arora NK, Frentzel E, Cowans T, et al. Development and Testing of the CAHPS Cancer Care Survey. J Oncol Pract. 2019;15(11):e969–e78. doi: 10.1200/JOP.19.00039 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Zolnierek KB, Dimatteo MR. Physician communication and patient adherence to treatment: a meta-analysis. Med Care. 2009;47(8):826–34. doi: 10.1097/MLR.0b013e31819a5acc [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Maria Elisabeth Johanna Zalm

14 Sep 2022

PONE-D-22-06849Patient-Centered Communication (PCC) Scale:  Psychometric Analysis and Validation of a Health Survey MeasurePLOS ONE

Dear Dr. Moser,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Your manuscript has been assessed by two peer-reviewers and their reports are appended below.  The reviewers comment that the manuscript could be strengthened by including a discussion on how the ceiling effect reported in this study compares to the ceiling affects reported in other similar studies. In addition, the reviewers request that more information is provided on ow the CFA fit was evaluated. Could you please carefully revise the manuscript to address all comments raised?

Please submit your revised manuscript by Oct 29 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Maria Elisabeth Johanna Zalm, Ph.D

Editorial Office

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please include your tables as part of your main manuscript and remove the individual files. Please note that supplementary tables (should remain/ be uploaded) as separate "supporting information" files".

3. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This is a really nicely done study that is written clearly. I have only a minor comment. As the measure has such a pronounced ceiling effect (33% of respondents having a "perfect" score, I was hoping the authors could comment on how this compares to ceiling effects of other patient-reported measures of provider communication, such as the CAT (Makoul) or the CAHPS communication items (AHRQ). Have the authors considered what cutpoints might be useful (e.g., perfect scores against all else; three tiers perfect, good, inadequate) to deal with these ceiling effects?

Reviewer #2: This high quality manuscript describes the psychometric validation of a 7-item patient-centered communication scale in a large nationally representative sample of U.S. adults. Due to the paucity of well-validated communication scales, this work is a valuable contribution.

No major concerns. This study appropriately evaluated the psychometric properties of the instrument as could be done with the available data.

Minor concerns: Information about how the CFA fit was to be evaluated (“For the CFA, fit was

determined using the following fit indices: Root Mean Square Error of Approximation (RMSEA,

cut off <.08), Comparative Fit Index (CFI, cut off >.90), Tucker Lewis Index (TLI, cut off >.95),

and Standardized Root Mean Square Residual (SRMR, cut off <.08). We did not report the chi

square statistic fit as research has found that this test is sensitive to large sample sizes”) should be provided in the Methods section instead of Results. Similarly, in the section on discriminant validity, for the point about not reporting p-values for correlation coefficients.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2022 Dec 30;17(12):e0279725. doi: 10.1371/journal.pone.0279725.r002

Author response to Decision Letter 0


4 Nov 2022

Note this information was also included in a separate document uploaded previously.

Dear Editor: Thanks for the opportunity to respond to the reviewers’ comments. Below you’ll see the comments and our response to each point in red.

Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This is a really nicely done study that is written clearly. I have only a minor comment. As the measure has such a pronounced ceiling effect (33% of respondents having a "perfect" score, I was hoping the authors could comment on how this compares to ceiling effects of other patient-reported measures of provider communication, such as the CAT (Makoul) or the CAHPS communication items (AHRQ). Have the authors considered what cutpoints might be useful (e.g., perfect scores against all else; three tiers perfect, good, inadequate) to deal with these ceiling effects?

Response: Thank you for this comment. We agree that the PCC showed higher than ideal ceiling effects. However, due to the communication-focused construct, and number of items, this was not unexpected. For example, the PCC ceiling effect is comparable to CAHPS (we’re not familiar with the CAT measure). We have added a reference and additional information about this on pages 15 and 16. Fortunately, the PCC also reported a minimal floor effect (0.2%). Therefore, we can feel comfortable to conclude this validation is sensitive to communication deficits. This has been noted both in the Discussion and Conclusion sections.

We also agree that PCC cut-points and percentiles would be incredibly useful to examine communication-focused research questions. However, our psychometric analyses were designed to evaluate the scale’s item-level properties, and an overall evaluation of the total scale score. We strongly encourage investigators to consider common cut-points and percentiles, based on their proposed research questions and target population and added this information to the conclusion.

Reviewer #2: This high quality manuscript describes the psychometric validation of a 7-item patient-centered communication scale in a large nationally representative sample of U.S. adults. Due to the paucity of well-validated communication scales, this work is a valuable contribution.

Response: We’re very happy to hear this is considered a valuable contribution.

No major concerns. This study appropriately evaluated the psychometric properties of the instrument as could be done with the available data.

Response: We appreciate this positive comment.

Minor concerns: Information about how the CFA fit was to be evaluated (“For the CFA, fit was

determined using the following fit indices: Root Mean Square Error of Approximation (RMSEA,

cut off <.08), Comparative Fit Index (CFI, cut off >.90), Tucker Lewis Index (TLI, cut off >.95),

and Standardized Root Mean Square Residual (SRMR, cut off <.08). We did not report the chi

square statistic fit as research has found that this test is sensitive to large sample sizes”) should be provided in the Methods section instead of Results. Similarly, in the section on discriminant validity, for the point about not reporting p-values for correlation coefficients.

Response: The information noted here was moved from the Results to the Statistical Analysis subsection on pages 9-10 in the Methods section.

Attachment

Submitted filename: Moser response to reviewers.docx

Decision Letter 1

Nabi Nazari

14 Dec 2022

Patient-Centered Communication (PCC) Scale:  Psychometric Analysis and Validation of a Health Survey Measure

PONE-D-22-06849R1

Dear Dr. Moser,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Nabi Nazari, PhD

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The comments have been addressed adequately. My sincere thanks to the authors for their responsiveness.

Reviewer #2: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

Acceptance letter

Nabi Nazari

20 Dec 2022

PONE-D-22-06849R1

Patient-Centered Communication (PCC) Scale:  Psychometric Analysis and Validation of a Health Survey Measure

Dear Dr. Moser:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Nabi Nazari

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Attachment

    Submitted filename: Moser response to reviewers.docx

    Data Availability Statement

    All data used for this manuscript are available to the public and can be accessed through this site after accepting a data use agreement: https://hints.cancer.gov/data/download-data.aspx. This study specifically used the HINTS 5 Cycle 2 data (2018).


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES